CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
66 hedge funds and large institutions have $44.3M invested in Cascadian Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
66
Increased
–
Reduced
–
Closed
–
Calls
$3.3M
Puts
$409K
Net Calls
+$2.89M
Net Calls Change
+$2.89M
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$12.6M |
| 2 |
2
Millennium Management
New York
|
$3.31M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$3.22M |
| 4 |
4
First Manhattan
New York
|
$3.07M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.41M |
Top Sellers
No sellers this quarter
